Metraipolis › archive › dc_87d7c46eb555
A small HER2 reader for routine H&E slides: real-world deployment — arXiv:2610.40662
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2610.40662
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-03T08:12:43.131Z
- SHA-256 of the archived text
539a51b742d4a5ad972fd9a28edcb74e31870b9bf78db782feaa99f31aba19eb- Stable URL of this page
https://metraipolis.com/documento/dc_87d7c46eb555
How to cite
A small HER2 reader for routine H&E slides: real-world deployment — arXiv:2610.40662 — arXiv (en), https://arxiv.org/abs/2610.40662 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_87d7c46eb555 (Metraipolis archive dc_87d7c46eb555, sha256 539a51b742d4a5ad972fd9a28edcb74e31870b9bf78db782feaa99f31aba19eb)
BibTeX
@misc{dc87d7c46eb555,
title = {A small HER2 reader for routine H&E slides: real-world deployment — arXiv:2610.40662},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2610.40662},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_87d7c46eb555; sha256 539a51b742d4a5ad972fd9a28edcb74e31870b9bf78db782feaa99f31aba19eb},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.40662. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
HER2 status decides who receives HER2-targeted therapy. Pathologists score HER2 protein by immunohistochemistry (IHC); equivocal IHC 2+ tumours, their hardest calls, wait for in situ hybridisation (ISH). We built a HER2 reader for routine H&E slides, owned end to end, as a baseline for pathologists. A 22M-parameter ViT-S/16 tile encoder was trained on public TCGA slides by self-supervision, distillation from H-optimus-0 and two rounds of JEPA refinement; five cross-validated attention-based slide classifiers average their probabilities; and an operating point is fixed on training data. Compared under one paired ten-seed protocol, readers on our encoder rank first of 7 on external validation from TCGA-BRCA to Yale-HER2 (AUC 0.812), level with readers on encoders 4 and 50 times larger. We also rebuilt PathBench's encoder benchmark on public cohorts; our replica reproduces its published order of reference encoders, and under it our encoder ranks first of 7 on TCGA-BRCA (0.689) and sits level with H-optimus-0 and Phikon on Yale-HER2 (0.897). On three external hospitals our deployed reader reaches AUC 0.82 on Yale-HER2 (about 0.81 with training slides balanced for tissue size), 0.75 on HEROHE and 0.63 on BCNB biopsies, and among HEROHE's 85 IHC 2+ cases it ranks ISH-amplified above non-amplified tumours at 0.76, best among our TCGA-trained readers. Per-laboratory score normalisation and a laboratory's own slides improve it further on a new site. Without a GPU our reader needs 5-6 s per slide. It serves as a research-use pre-read in a pathology platform, where it proposes a probability and a call beside IHC and helps prioritise ISH for equivocal cases. Weights, per-slide predictions and the data behind every figure are public at this https URL . Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.LG, nuovi lavori del giorno). Categorie arXiv: Quantitative Methods (q-bio.QM) ; Computer Vision and Pattern Recognition (cs.CV); Machine Learning (cs.LG); Software Engineering (cs.SE). Pagina del lavoro: https://arxiv.org/abs/2610.40662 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-11-03T08:02:38.959Z dalla pagina https://arxiv.org/list/cs.LG/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).